Abstract: An automated method for remote computing of molecular docking and dynamics from one or more jobs in a network of plurality of users. The invention employs a system to execute the method comprising at least one user device, a remote computing server and a remote database. The job defining action tags are received and scanned by the remote server. A semantic analysis is performed on the jobs to distinguish between customized and non-customized tasks. A data analysis of the jobs is packaged in a compressed format. The user is continually updated of the job status. A public link is generated and sent to the user to download the results. The link is disabled after the downloading of the results to ensure the security of the data. The method avoids any duplication of jobs and can be performed even when the user is offline.

Abstract: The present invention relates to novel polymerization catalysts. More particularly, the present invention relates to a novel catalysts for the preparation of ultra high molecular weight polyethylene (UHMWPE) and process for preparation thereof. The present invention further relates to a process for the preparation of disentangled ultra high molecular weight polyethylene (dis-UHM-WPE).

Abstract: The invention relates to the development of a simple and eco-friendly process of extraction of sweet glycosides: steviosides from the leaves of Stevia rebaudiana. In particular, certain embodiments provide enhanced isolation of steviosides by enzyme assisted extraction, in combination with metal salts, followed by pressurized aqueous extraction. Thus obtained stevia extract was further processed for clarification and purification using multi-stage membrane filters (micro-filtration, ultra-filtration and nano membrane filtration) to obtain high purity steviosides from the Stevia leaves. This improved process confirms the isolation of high purity steviol glycosides i.e., Stevioside and Rebaudioside-A as the final products, with improved organoleptic properties. Thus, this superior process helps in obtaining pure steviosides from the Stevia leaf extract, without impurities and obnoxious residues, using easy operational technology without any damage to the environment.

Abstract: Substituted heterocyclic compounds and/or aromatic compounds containing amide and/or urea groups exhibit resonance in the range of 0.1-10 THz. Binary molecular complexes can be based on the substituted heterocyclic compounds and/or aromatic compounds containing amide and/or urea groups. The compounds and binary molecular complexes have varying molecular mass and hydrogen bond strengths demonstrating several resonances below 10 THz. The compounds and binary molecular complexes are customizable for various applications, such as authentication of a product.

Abstract: The invention discloses a composition comprising surface modified iron oxide nanoparticles with citric acid modified cyclodextrin with a hydrodynamic diameter of less than 10 nm and a hydrophobic molecule. The composition finds use in targeted delivery of a hydrophobic drug and as contrast agent in imaging applications.

Abstract: The present invention relates to an anaerobic column reactor for biodegradation of wastes. Particularly the present invention relates to a process for conversion of biodegradable wastes to biogas and compost. More particularly, the present invention relates to an anaerobic reactor with unique arrangement of expanded and constricted portions alternatively placed vertically over each other which enhances the mixing pattern and thereby the mass transfer rates while controlling the biomass washout by regulating the upflow liquid velocity.

Abstract: The present invention discloses a catalytic process for the manufacture of hydrogen and hydrocarbons simultaneously in the same reactor from renewable source, i.e. lipids, glycerides and fatty acids from plant, animal or algae oil, where in the multiple unsaturations in the renewable feedstock and the catalytic intermediates produced in the process from renewable feedstock is converted catalytically using simultaneous combination of in-situ occurring reactions. These in-situ occurring reactions are simultaneous combination of hydroconversion, reforming and water gas shift reactions wherein the reaction is performed in the presence of one or more metal sulfides form of metals of Group VI and/or Group IX and/or Group X elements, specifically comprises of one or more active metal combinations such as Co, W, Mo, Ni, P, with Pt, Pd encapsulated inside sodalite cages for prevention against poisoning from sulfur based compounds.

Abstract: The present invention relates to a novel phenonthroline based pincer complexes and process for preparation thereof. The present invention also provides a one pot process for the conversion of carbon dioxide to methanol in the presence of a molecularly defined pincer-type single-site Ru-catalyst and secondary amine. Further the present invention provides the use of phenonthroline based pincer complexes for the esterification of alcohols and hydrogenation of esters under mild conditions.

Abstract: The present invention discloses a process for preparing a homogeneous solution of a polymer and melanin. The present invention further discloses a process for preparation of fibers and films from said homogeneous solution.

Abstract: The present invention provides a single step process for the synthesis of furfuryl ethyl ether comprises refluxing the reaction mixture of furfuryl alcohol, ethanol and catalyst at temperature in the range of 80 to 120° C. for the period in the range of 3 to 7 hrs to afford furfuryl ethyl ether. The catalyst used in present invention is Zr incorporated SBA-15. Further, the conversion of furfuryl alcohol is in the range of 60 to 90%. The selectivity of reaction towards furfuryl ethyl ether is in the range of 85 to 95%.

Abstract: The present disclosure relates to the synergistic liposomal formulation comprising, phophatidylcholine, stearylamine and anticancer drugs for the treatment of cancer. The PC:SA cationic liposome encapsulated camptothecin (CPT) and doxorubicin (DOX) formulations show enhanced synergistic anti-cancer effect and provide improved therapeutic index as compared to either the liposome or drug alone. The present disclosure also relates to the use of Cationic liposomal preparation of phosphatidylcholine:stearylamine (PC:SA) showing anticancer effect. The SA-bearing liposome and drug entrapped in the liposome are effective against cancer both in vitro and in vivo, without causing any adverse effect on host.

Abstract: The present invention involves the isolation of plant based CNCs from the leaves of S. cumini. For the formation of NCs, a novel greener approach using S. cumini LE as reducing agent for in situ impregnation of AgNPs as fillers into CNCs as matrix is reported. The silver nitrate solution in three different concentrations of 1 mM, 5 mM and 10 mM was used to form NCs where AgNPs have been incorporated into CNCs matrix. The CNCs and NCs were characterized using SEM, TEM, XRD, Zeta potential, FT-IR, and UV-Vis spectroscopy. NCs developed in the form of film and ointment showed strong antimicrobial activity against both gram negative and gram positive bacteria. NCs wound dressing is capable of regulating wound exudates and providing moisture to wound responsible for faster healing of acute wounds. The observations from histopathological and biochemical assays confirmed that NCs enhance healing because of lesser inflammation, rapid angiogenesis, early collagen formation and enhanced rate of reepithelization.

Abstract: The present invention relates to isomerizing hydroformylation of plant oils to feedstock chemicals and monomers. More particularly, the present invention relates to compound of formula (I) and process for preparation thereof using isomerizing functionalization of cashew nut shell liquid (CNSL).

Abstract: The present invention discloses a method for preventing retraction of aqueous drops on a hydrophobic surface. The present invention also discloses a medical device coated with a hydrophilic coating comprising a substrate and a coating composition.

Abstract: The present invention relates to a process for the preparation of racemic nicotine from 3-pyridylaldehyde using a one-pot or step-wise method. The process comprises the following steps: Stetter reaction, reduction-cyclization and methylation.

Abstract: The present invention relates to a self assembled catalyst. More particularly, the present invention relates to a self-assembled catalyst of formula (I) comprising supramolecular phosphine and carboxylate ligands, process for preparation thereof and use of said catalyst of formula (I) in olefin polymerization.

Abstract: A compound of general formula A, useful as potential anticancer agents against human cancer cell lines and process for the preparation thereof. General formula A R1=3-F, 3,4,5-OMe, 4-OMe, H, 4-CF3, 4-Cl, 4-OH-3-OMe, 3,4-CH2—O—CH2, 3,5-F, 4-OH, 1-napthyl, 9-phenanthryl, 4-Me. R2=3,4,5-OMe, 3,4-Cl, 4-F, 3,5-F, 2,5-OMe, 4-Cl, 4-OH-3-OMe, 3-OH, 3,4,5-OH, 4-CF3, 4-OMe, 4-NH2.

Abstract: An electrode, process for preparing the electrode and devices thereof. An electrode comprising at least one metal deposited on a substrate; and at least one electrically conducting polymer. The devices comprising the electrode for energy storage and molecular separation.

Abstract: The present invention relates to a complete process for preparation of high flux and salt rejection thin film composite (TFC) reverse osmosis (RO) membrane including process for preparation of support membrane for thin film, process for thin film coating of support membrane by in-situ interfacial polymerization between diamines and trimesoyl chloride, machine design, chemistry and details of process (engineering+chemistry+ambient) parameter at 1×100 sqm scale upgradeable to a scale even 10-20 times higher. The produced membrane is characterized by 96% salt rejection and 48 LM-2H 1 flux with 2000 ppm sodium chloride solution at 250 psi pressure and 95% salt rejection and 46 LM2H 1 flux with 35000 ppm sodium chloride solution at 900 psi pressure. The present invention also relates to complete machine design for PSF ultrafiltration membrane casting and coating for TFC membrane production at commercial level.

Abstract: The present invention discloses novel peptides acting as angiotensin II analog for therapeutic applications. Said peptides can be used for treatment of Alzheimer's and other neurological and cognitive disorders.